2m 2m 2m 2m 2m 2m 2m
MBX BIO (MBX)
NASDAQ
$59.03+$0.005 (+0.008%)
Price as of Sep 11, 2026 7:30 PM EDT- $2.8BMarket Cap
- 444.97%1-Year Change
- BiotechnologyIndustry
MBX BIO (MBX)
$59.03+$0.005 (+0.008%)
Top Holders
Institutional
Mutual Funds
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 13.98% | 6.7M | 0 (0.00%) | Jun 30, 2026 |
FMR LLC | 11.18% | 5.3M | +2.4M (+44.83%) | Jun 30, 2026 |
WELLINGTON MANAGEMENT GROUP LLP | 10.46% | 5.0M | +1.8M (+35.88%) | Jun 30, 2026 |
NEA MANAGEMENT COMPANY, LLC | 7.59% | 3.6M | 0 (0.00%) | Jun 30, 2026 |
ORBIMED ADVISORS LLC | 7.20% | 3.4M | -209,151 (-6.10%) | Jun 30, 2026 |
BLACKROCK, INC. | 6.98% | 3.3M | +382,266 (+11.50%) | Jun 30, 2026 |
PARADIGM BIOCAPITAL ADVISORS LP | 5.27% | 2.5M | +2.5M (+100.00%) | Jun 30, 2026 |
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
iSHARES TRUST | 3.18% | 1.5M | +182,695 (+12.08%) | Jun 30, 2026 |
VANGUARD INDEX FUNDS | 3.03% | 1.4M | -322 (-0.02%) | Jun 30, 2026 |
MUTUAL FUND SERIES TRUST | 1.84% | 873,492 | -16,508 (-1.89%) | Jun 30, 2026 |
FIDELITY SECURITIES FUND | 1.57% | 748,750 | +715,061 (+95.50%) | Apr 30, 2026 |
FIDELITY SELECT PORTFOLIOS | 1.41% | 673,100 | +393,100 (+58.40%) | May 31, 2026 |
FRANKLIN STRATEGIC SERIES | 1.41% | 671,791 | 0 (0.00%) | Apr 30, 2026 |
FIDELITY ADVISOR SERIES VII | 1.27% | 604,600 | +493,500 (+81.62%) | Apr 30, 2026 |
Current Ownership Distribution
- Institutions277.7M (85.90%)
- Mutual Funds44.6M (13.81%)
- Insiders959,004 (0.30%)
- Other0 (0.00%)
Insider Transactions
- 0.30% (959,004)Current InsiderOwnership (%, shares)
- 3Number of InsiderBuying (last 12 months)
- $95.3MAmount of InsiderBuying (last 12 months)
- 0Number of InsiderSelling (last 12 months)
- $0.00Amount of InsiderSelling (last 12 months)
Insider Name & Title | Type | Date
| Transaction Value | Shares | Share Price | Shares After Transactions |
|---|---|---|---|---|---|---|
Hawryluk P. Kent President & CEO | Buy | Mar 13, 2026 | $525,662.70 | 18,500 | $28.41 | 486,777 |
Hawryluk P. Kent President & CEO | Exempt | Feb 26, 2026 | $0.00 | 28,768 | $0.00 | 91,668 |
Hawryluk P. Kent President & CEO | Exempt | Feb 26, 2026 | $460,288.00 | 28,768 | $16.00 | 728,274 |
Hawryluk P. Kent President & CEO | Award | Feb 02, 2026 | $0.00 | 164,500 | $0.00 | 164,500 |
Bartram Richard Chief Financial Officer | Award | Feb 02, 2026 | $0.00 | 70,000 | $0.00 | 70,000 |
Hawryluk P. Kent President & CEO | Award | Feb 02, 2026 | $0.00 | 35,250 | $0.00 | 699,506 |
Azoulay Salomon Chief Medical Officer | Award | Feb 02, 2026 | $0.00 | 70,000 | $0.00 | 70,000 |
Bartram Richard Chief Financial Officer | Award | Feb 02, 2026 | $0.00 | 15,000 | $0.00 | 15,000 |
Azoulay Salomon Chief Medical Officer | Award | Feb 02, 2026 | $0.00 | 15,000 | $0.00 | 15,000 |
Stelzer Laurie | Award | Jan 20, 2026 | $0.00 | 32,000 | $0.00 | 32,000 |
Hoerter Steven L. | Buy | Oct 17, 2025 | $264,984.00 | 20,000 | $13.25 | 20,000 |
Heron Patrick J | Buy | Sep 26, 2025 | $12.0M | 666,666 | $18.00 | 5.2M |
Pescovitz Ora H. | Buy | Apr 08, 2025 | $45,311.77 | 7,693 | $5.89 | 24,329 |
GORDON CARL L | Buy | Feb 18, 2025 | $531,918.80 | 49,070 | $10.84 | 3.3M |
ORBIMED ADVISORS LLC | Buy | Feb 18, 2025 | $531,918.80 | 49,070 | $10.84 | 3.3M |
GORDON CARL L | Buy | Feb 18, 2025 | $1.0M | 94,100 | $10.84 | 747,887 |
ORBIMED ADVISORS LLC | Buy | Feb 18, 2025 | $1.0M | 94,100 | $10.84 | 747,887 |
GORDON CARL L | Buy | Feb 14, 2025 | $177,823.80 | 17,962 | $9.90 | 3.2M |
ORBIMED ADVISORS LLC | Buy | Feb 14, 2025 | $177,823.80 | 17,962 | $9.90 | 3.2M |
GORDON CARL L | Buy | Feb 14, 2025 | $290,969.00 | 29,540 | $9.85 | 3.2M |
ORBIMED ADVISORS LLC | Buy | Feb 14, 2025 | $290,969.00 | 29,540 | $9.85 | 3.2M |
Hawryluk P. Kent President & CEO | Buy | Feb 04, 2025 | $534,500.00 | 50,000 | $10.69 | 448,277 |
Azoulay Salomon Chief Medical Officer | Award | Feb 03, 2025 | $0.00 | 90,000 | $0.00 | 90,000 |
Bartram Richard Chief Financial Officer | Award | Feb 03, 2025 | $0.00 | 95,000 | $0.00 | 95,000 |
Hawryluk P. Kent President & CEO | Award | Feb 03, 2025 | $0.00 | 243,000 | $0.00 | 243,000 |